NOT KNOWN FACTS ABOUT ESTAZOLAM

mavorixafor will boost the degree or effect of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Watch for adverse outcomes of sensitive CYP3A4 substrates if coadministered with mavorixafor (a weak CYP3A4 inhibitor).Tolerance to estazolam may create from continued therapy. Tolerance is actually a physiological